Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.01 by 900 percent. The company reported quarterly sales of $67.80 million which beat the analyst consensus estimate of $57.69 million by 17.52 percent. This is a 24.37 percent increase over sales of $54.52 million the same period last year.